Frederick W. Alt

Frederick W. Alt

Charles A. Janeway Professor of Pediatrics
Frederick W. Alt
The broad focus of the Alt lab is the elucidation of mechanisms that generate antigen receptor diversity in the Immune system and mechanisms that maintain genomic stability in mammalian cells. Over the past decade we have developed remarkably sensitive high throughput approaches to elucidate translocations and DNA breaks genome-wide at nucleotide resolution and move studies of chromosomal translocations, deletions, and amplifications into the post-genomics era. More recently, we have further advanced these methods to develop powerful V(D)J recombination and IgH class switch recombination assays that have led to us to generate a much more in depth understanding of the mechanistic aspects of these processes in B lymphocyte lineage cells and the role of topological chromatin domains and chromosomal loop domains in influencing DSB generation and joining during these processes. Our studies have also revealed many new insights into mechanisms by which off-target activities associated with the antigen receptor locus gene rearrangement processes in B and T lineage cells lead to oncogenic genomic rearrangements and lymphoid cancers. We have further exploited our discoveries in these general areas to generate powerful new mouse models to test vaccination strategies for generating human HIV-1 broadly neutralizing antibodies and for optimizing or discovering human therapeutic antibodies more generally. We also have further advanced our high throughput V(D)J recombination assays to develop a highly sensitive antibody somatic hypermutation/affinity maturation assay (“Landmarc”-Seq) that has allowed us to directly address the enigmatic nature of chronic gut Peyer's Patch (PP) antibody repertoires in mice and we are now extending these studies to humans. Finally, as a complementary goal to our immunology studies, we have extended our research focus to employ our powerful new approaches to discover genes that recurrently break in neuronal stem and progenitor cells, potentially providing new insights into potential mechanisms of cellular diversity in the brain and mechanistic factors that could contribute various neuropsychiatric diseases and brain cancer.

Contact Information

Boston Children's Hospital
Karp Family Research Building, Rm. 09216
One Blackfan Circle
Boston, MA 02115
p: 617-919-2539

Experimental Approach

Organism